HCPCS Level IItemporaryActive
Q2058
Obecbtge autol up to 400 mil
BETOS: O1D
Effective: 2025-07-01
Referenced in 1 policies
Description
Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
Drug Products
FDA-registered drug products mapped to this HCPCS code
AUCATZYL
NDC: 83047-0410-04IV